We are live on ! Find out more
PM

Parametrica Management Portfolio holdings

AUM $88M
1-Year Est. Return 48.84%
This Fund
S&P 500
This Quarter Est. Return
+28.81%
1 Year Est. Return
+48.84%
3 Year Est. Return
+257.17%
5 Year Est. Return
+315.15%
10 Year Est. Return
–
AUM
$55.4M
AUM Growth
+$6.65M
Cap. Flow
-$139K
Cap. Flow %
-0.25%
Top 10 Hldgs %
76.73%
Holding
54
New
8
Increased
11
Reduced
5
Closed
28

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$3.86M
2
BEKE icon
KE Holdings
BEKE
+$3.77M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.15M
4
MSFT icon
Microsoft
MSFT
+$2.75M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.36M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$3.82M
2
JD icon
JD.com
JD
+$3.46M
3
BABA icon
Alibaba
BABA
+$3.27M
4
WOLF icon
Wolfspeed
WOLF
+$2.31M
5
IBB icon
iShares Biotechnology ETF
IBB
+$1.93M

Sector Composition

Rank Sector Weight
1 Communication Services 34.96%
2 Technology 28.81%
3 Healthcare 20.59%
4 Consumer Discretionary 8.71%
5 Real Estate 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.9T
$7.88M 14.23%
27,346
+10,796
+65% +$2.75M
META icon
2
Meta Platforms (Facebook)
META
$1.49T
$7.84M 14.15%
37,000
+22,638
+158% +$3.86M
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.12T
$7.1M 12.81%
68,407
+32,807
+92% +$3.15M
BEKE icon
4
KE Holdings
BEKE
$18.4B
$3.84M 6.93%
+203,892
New +$3.77M
BIDU icon
5
Baidu
BIDU
$35.7B
$3.39M 6.11%
22,432
+7,232
+48% +$1.03M
PDD icon
6
Pinduoduo
PDD
$126B
$3.29M 5.94%
43,375
+25,400
+141% +$2.3M
LLY icon
7
Eli Lilly
LLY
$1.08T
$2.69M 4.85%
7,827
+627
+9% +$211K
REGN icon
8
Regeneron Pharmaceuticals
REGN
$72.9B
$2.57M 4.63%
+3,123
New +$2.36M
NVO
9
Novo Nordisk
NVO
$228B
$2.39M 4.31%
30,000
+2,200
+8% +$156K
MELI icon
10
Mercado Libre
MELI
$94.5B
$1.54M 2.77%
+1,165
New +$1.33M
ADBE icon
11
Adobe
ADBE
$105B
$1.53M 2.76%
+3,968
New +$1.41M
NOW icon
12
ServiceNow
NOW
$120B
$1.46M 2.63%
15,700
+3,535
+29% +$308K
NVDA icon
13
NVIDIA
NVDA
$4.6T
$1.41M 2.54%
50,630
-26,910
-35% -$582K
LNTH icon
14
Lantheus
LNTH
$6.51B
$1.26M 2.28%
15,300
+1,100
+8% +$70.9K
AMAT icon
15
Applied Materials
AMAT
$347B
$1.25M 2.26%
10,200
+1,432
+16% +$164K
AMD icon
16
Advanced Micro Devices
AMD
$700B
$1.2M 2.16%
12,200
-5,200
-30% -$423K
ALNY icon
17
Alnylam Pharmaceuticals
ALNY
$38.3B
$1.19M 2.15%
5,953
-3,547
-37% -$746K
YMM icon
18
Full Truck Alliance
YMM
$10B
$1.08M 1.94%
141,513
-15,226
-10% -$121K
MTCH icon
19
Match Group
MTCH
$9.19B
$1.05M 1.89%
+27,251
New +$1.19M
TXG icon
20
10x Genomics
TXG
$5.88B
$801K 1.45%
+14,361
New +$671K
IOVA icon
21
Iovance Biotherapeutics
IOVA
$2.04B
$298K 0.54%
48,700
+800
+2% +$5.52K
ARBE icon
22
Arbe Robotics
ARBE
$73.3M
$109K 0.2%
+34,287
New +$138K
FATE icon
23
Fate Therapeutics
FATE
$275M
$105K 0.19%
18,472
-13,782
-43% -$83.2K
IPSC icon
24
Century Therapeutics
IPSC
$364M
$96.6K 0.17%
27,840
– –
SABR icon
25
Sabre
SABR
$716M
$51.5K 0.09%
+12,000
New +$68.7K
1
2 3

Similar funds

BCP
Balance Capital Partners New York $87.9M AUM
PBCM
Point Break Capital Management Miami, Florida $88M AUM
CVM
Civilization Ventures Management Belvedere Tiburon, California $87.9M AUM
XXIP
Xiamen Xinweidachuang Investment Partnership Xiamen, China $87.8M AUM 29.25% 1-Year Est. Return
DG
Daventry Group New York $87.8M AUM 3.83% 1-Year Est. Return
RFL
RD Finance Ltd Limassol, Cyprus $88.1M AUM 11.44% 1-Year Est. Return
IAP
Indie Asset Partners Carmel, Indiana $87.8M AUM 27.76% 1-Year Est. Return
MPEM
Marathon Partners Equity Management New York $88.3M AUM 20.65% 1-Year Est. Return

Parametrica Management's Q1 2023 Portfolio in Review

As of Q1 2023, Parametrica Management held 54 positions worth $55.4M, up 14% from $48.8M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Parametrica Management's Q1 2023 filing shows 8 new, 11 increased, 5 reduced and 28 closed positions. Its largest new stake was KE Holdings: 203,892 shares worth $3.84M. The largest sale was Pfizer, an estimated $3.82M.

By sector, the portfolio is most concentrated in Communication Services at 35% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • Parametrica Management's largest Q1 2023 buy was KE Holdings: 203,892 shares worth $3.84M.
  • Parametrica Management added most to Meta Platforms (Facebook) in Q1 2023, an estimated $3.86M increase.
  • Parametrica Management's biggest Q1 2023 reduction was Alnylam Pharmaceuticals, cutting an estimated $746K.
  • Parametrica Management fully exited Pfizer in Q1 2023, selling an estimated $3.82M.
  • Parametrica Management's ten largest holdings make up 77% of its $55.4M portfolio in Q1 2023.
  • Parametrica Management opened 8 new positions and closed 28 in Q1 2023.
  • Parametrica Management's portfolio value rose 14% quarter-over-quarter to $55.4M.

Based on Parametrica Management's 13F filing for Q1 2023, filed 9 May 2023.